Interaction between immobilized polyelectrolyte complex nanoparticles and human mesenchymal stromal cells

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2205-2215

  Woltmann, Beatrice ^a   Torger, Bernhard ^a,b   Müller, Martin ^a,b   Hempel, Ute ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

Author keywords

Biocompatibility; Mesenchymal stromal cells; Morphology; MTS assay; Polyelectrolyte complex nanoparticles

Indexed keywords

(N,N DIETHYLAMINO)ETHYLDEXTRAN; CELLULOSE SULFATE; DEXTRAN DERIVATIVE; DEXTRAN SULFATE; NANOPARTICLE; POLYETHYLENEIMINE; POLYLYSINE; UNCLASSIFIED DRUG; ELECTROLYTE; POLYMER;

ARTICLE; BIOCOMPATIBILITY; CELL INTERACTION; CELL METABOLISM; CELL STRUCTURE; CHEMICAL COMPOSITION; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMOBILIZATION; INTERNALIZATION; MESENCHYMAL STROMA CELL; MOLECULAR INTERACTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING FORCE MICROSCOPY; SURFACE CHARGE; ADSORPTION; CELL SIZE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; MATERIALS TESTING; METABOLISM; STATIC ELECTRICITY; ULTRASTRUCTURE;

ADSORPTION; CELL SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROLYTES; HUMANS; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; PARTICLE SIZE; POLYMERS; STATIC ELECTRICITY;

EID: 84900402591     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S61198     Document Type: Article

References (45)

1. Hayda RA, Brighton CT, Esterhai JL Jr. Pathophysiology of delayed healing. Clin Orthop Relat Res. 1998;355 Suppl:S31-S40.
2. Mundy GR. Pathogenesis of osteoporosis and challenges for drug delivery. Adv Drug Deliv Rev. 2000;42(3):165-173.
3. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23-57.
4. Jones CB. Augmentation of implant fixation in osteoporotic bone. Curr Osteoporos Rep. 2012;10(4):328-336.
5. Pesce V, Speciale D, Sammarco G, Patella S, Spinarelli A, Patella V. Surgical approach to bone healing in osteoporosis. Clin Cases Miner Bone Metab. 2009;6(2):131-135.
6. Granero-Moltó F, Weis JA, Miga MI, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009;27(8):1887-1898.
7. Neman J, Hambrecht A, Cadry C, Jandial R. Stem-cell mediated osteogenesis: therapeutic potential for bone tissue engineering. Biologics. 2012;6:47-57.
8. Gostin PF, Helth A, Voss A, et al. Surface treatment, corrosion behavior, and apatite-forming ability of Ti-45Nb implant alloy. J Biomed Mater Res B Appl Biomater. 2013;101(2):269-278.
9. Schliephake H, Bötel C, Förster A, Schwenzer B, Reichert J, Scharnweber D. Effect of oligonucleotide mediated immobilization of bone morphogenic proteins on titanium surfaces. Biomaterials. 2012;33(5):1315-1322.
10. Brammer KS, Choi C, Frandsen CJ, Oh S, Johnston G, Jin S. Comparative cell behavior on carbon-coated TiO2 nanotube surfaces for osteoblast vs osteo-progenitor cells. Acta Biomater. 2011;7(6):2697-2703.
11. Polini A, Pisignano D, Parodi M, Quarto R, Scaglione S. Osteoinduction of human mesenchymal stem cells by bioactive composite scaffolds without supplemental osteogenic growth factors. PLoS One. 2011;6(10):e26211. Epub 2011 Oct 12.
12. Kang Y, Scully A, Young DA, Kim S, Tsao H, Sen M. Enhanced mechanical performance and biological evaluation of PLGA coated β-TCP composite scaffold for load bearing applications. Eur Polym J. 2011;47(8):1569-1577.
13. Lock J, Liu H. Nanomaterials enhance osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7. Int J Nanomedicine. 2011;6:2769-2777.
14. Gentile P, Mattioli-Belmonte M, Chiono V, et al. Bioactive glass/polymer composite scaffolds mimicking bone tissue. J Biomed Mater Res A. 2012;100(10):2654-2667.
15. Chen QZ, Thompson ID, Boccaccini AR. 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials. 2006;27(11):2414-2425.
16. Tautzenberger A, Kovtun A, Ignatius A. Nanoparticles and their potential for application in bone. Int J Nanomedicine. 2012;7:4545-4557.
17. Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone. 2009;45(3):505-511.
18. Kabanov VA, Zezin AB. Soluble interpolymeric complexes as a new class of synthetic polyelectrolytes. Pure Appl Chem. 1984;56(3):343-354.
19. Philipp B, Dautzenberg H, Linow KJ, Kötz J, Dawydoff W. Polyelectrolyte complexes: recent developments and open problems. Progr Polym Sci. 1989;14(1):91-172.
20. Thünemann AF, Müller M, Dautzenberg H, Joanny JF, Löwen H. Polyelectrolyte complexes. Adv Polym Sci. 2004;166:113-171.
21. Müller M. Sizing, shaping and pharmaceutical applications of polyelectrolyte complex nanoparticles. Adv Polym Sci. 2014;256:197-260.
22. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm. 2011;8(6):2101-2141.
23. Torger B, Vehlow D, Urban B, Salem SR, Appelhans D, Müller M. Cast adhesive polyelectrolyte complex particle films of unmodified or maltose-modified poly(ethyleneimine) and cellulose sulphate: fabrication, film stability and retarded release of zoledronate. Biointerphases. 2013;8:25.
24. Müller M, Keßler B. Release of pamidronate from poly(ethyleneimine)/cellulose sulphate complex nanoparticle films: an in situ ATR-FTIR study. J Pharm Biomed Anal. 2012;66:183-190.
25. Bernsmann F, Richert L, Senger B, et al. Use of dopamine polymerisation to produce free-standing membranes from (PLL-HA)n exponentially growing multilayer films. Soft Matter. 2008;4(8):1621-1624.
26. Müller M, Keßler B, Richter S. Preparation of monomodal polyelectrolyte complex nanoparticles of PDADMAC/poly(maleic acid-alt-alpha-methylstyrene) by consecutive centrifugation. Langmuir. 2005;21(15):7044-7051.
27. Oswald J, Boxberger S, Jørgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377-384.
28. Tiyaboonchai W, Rodleang I, Ounaroon A. Mucoadhesive polyethylenimine-dextran sulfate nanoparticles containing Punica granatum peel extract as a novel sustained-release antimicrobial. Pharm Dev Technol. Epub 2014 Jan 17.
29. Hartig SM, Greene RR, DasGupta J, Carlesso G, Dikov MM, Prokop A, Davidson JM. Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res. 2007;24(12):2353-2369.
30. Hartig SM, Greene RR, Carlesso G, et al. Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells. Biomaterials. 2007;28(26):3843-3855.
31. Moreau E, Domurado M, Chapon P, Vert M, Domurad D. Biocompatibility of polycations: in vitro agglutination and lysis of red blood cells and in vivo toxicity. J Drug Target. 2002;10(2):161-173.
32. Morgan DM, Larvin VL, Pearson JD. Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. J Cell Sci. 1989;94(Pt 3):553-559.
33. Hunter AC. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev. 2006;58(14):1523-1531.
34. Ebbesen P. DEAE-dextran and polybrene cation enhancement and dextran sulfate anion inhibition of immune cytolysis. J Immunol. 1972; 109(6):1296-1299.
35. Mauersberger B, Mickwitz CUV, Zipper J, Azt J, Heder G. Studies on cytotoxicity of poly(L-arginine), poly(L-lysine) and DEAE-dextran in L-cells and mouse embryonic fibroblasts. Exp Pathol (Jena). 1977;13(4-5):268-274.
36. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24(7):1121-1131.
37. Takai T, Ohmori H. DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure. Biochim Biophys Acta. 1990;1048(1):105-109.
38. Parhamifar L, Larsen AK, Hunter AC, Andresen TL, Moghimi SM. Polycation cytotoxicity: a delicate matter for nucleic acid therapy - focus on polyethylenimine. Soft Matter. 2010;6(17):4001-4009.
39. Kamide K, Okajima K, Matsui T, Ohnishi M, Kobayashi H. Roles of molecular characteristics in blood anticoagulant activity and acute toxicity of sodium cellulose sulfate. Polym J. 1983;15(4):309-321.
40. Hint HC, Richter AW. Chronic toxicity of dextran sulphate in rabbits. Br J Pharmacol Chemother. 1958;13(2):109-112.
41. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657-3666.
42. Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7(10):1322-1337.
43. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505-515.
44. Tautzenberger A, Lorenz S, Kreja L, et al. Effect of functionalized fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation. Biomaterials. 2010;31(8):2064-2071.
45. Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577-5591.